Correspondence to: “Combination therapies with ponatinib and asciminib in a preclinical model of chronic myeloid leukemia blast crisis with compound mutations”, Curik N et al. Leukemia. 2024; 38: 1415–1418

Authors: Seiichi Okabe, Yuya Arai, Akihiko Gotoh

Published: 2025-02-06

DOI: 10.1038/s41375-025-02521-w

Source: Full article

---

Abstract

No abstract found.